Business

Mitsu Chem Plast Limited Reports INR 81 Cr Total Income In Q3 FY25

Feb 10, 2025

PNN
Mumbai (Maharashtra) [India], February 10: Mitsu Chem Plast Limited (Mitsu) (BSE:540078), a global leading player in polymer-based moldedproducts, particularly in hospital furniture parts, has announced its Unaudited Financial Results for Q3 & 9M FY25.
Key Financial Highlights
Q3 FY25 Key Financials at a Glance:
* Total Income of Rs 80.52 Cr
* EBITDA of Rs 5.51 Cr
* EBITDA Margin (%) of 6.84%
* Net Profit of Rs 1.49 Cr
* Net Profit Margin (%) of 1.85%
* EPS of Rs 1.09
9M Key Financials at a Glance:
* Total Income of Rs 242.37 Cr
* EBITDA of Rs 15.06 Cr
* EBITDA Margin (%) of 6.23%
* Net Profit of Rs 3.71 Cr
* Net Profit Margin (%) of 1.53%
* EPS of Rs 2.77
Commenting on the performance, Sanjay Dedhia, Managing Director of Mitsu Chem Plast Limited said, "Our growth trajectory remains strong, driven by consistent demand across key industries and our relentless focus on innovation, operational efficiency, and customer-centric solutions. Despite macroeconomic challenges, we have continued to expand our product portfolio and enhance our manufacturing capabilities, ensuring sustained value creation for our stakeholders. Additionally, our export segment has gained strong traction, reflecting the increasing global demand for our healthcare products and we have also added few countries in our portfolio. The steady improvement in revenue and profitability highlights our commitment to excellence and adaptability in a dynamic business environment. As we move forward, we remain focused on strengthening our market position, optimizing costs, and leveraging new opportunities--both domestic and international--to accelerate growth."
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same)

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025